D
Abeona Therapeutics Inc. ABEO
$5.27 -$0.22-4.01% NASDAQ
Recommendation
Prev Close
$5.27
Volume
1,151,275
Avg Vol (90D)
1,001,167
Market Cap
$255.77M
Dividend & Yield
--
52-Week Range
$3.93 - $7.32
P/E (TTM)
--
EPS (TTM)
-$2.24
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Abeona Therapeutics (ABEO, $5.27) entered Downtrend as Momentum indicator drops below 0 level on May 09, 2025
5/10/2025 - Tickeron - Technical Analysis
Abeona Therapeutics (ABEO, $5.27) Moving Average Convergence Divergence (MACD) Histogram turned negative on May 9, 2025
5/10/2025 - Tickeron - Technical Analysis
Abeona Therapeutics (ABEO, $5.49) Stochastic Oscillator left the oversold zone on May 08, 2025
5/9/2025 - Tickeron - Stocks
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
5/7/2025 - Globe Newswire
Abeona Therapeutics (ABEO, $6.4) RSI Indicator left the overbought zone on May 05, 2025
5/6/2025 - Tickeron - Technical Analysis
Renaissance Technologies LLC Has $497,000 Holdings in Abeona Therapeutics Inc (NASDAQ:ABEO)
5/6/2025 - MarketBeat
ABEO FY2025 EPS Forecast Boosted by Cantor Fitzgerald
5/4/2025 - MarketBeat
Q3 EPS Estimate for Abeona Therapeutics Boosted by Analyst
5/4/2025 - MarketBeat
Q2 EPS Forecast for Abeona Therapeutics Decreased by Analyst
5/4/2025 - MarketBeat
Abeona Therapeutics Inc (NASDAQ:ABEO) Sees Large Growth in Short Interest
5/4/2025 - Ticker Report
Abeona Therapeutics Inc (NASDAQ:ABEO) Short Interest Update
5/4/2025 - MarketBeat
Abeona Therapeutics (NASDAQ:ABEO) Price Target Raised to $20.00 at HC Wainwright
5/2/2025 - MarketBeat
Abeona Therapeutics (ABEO) Gains FDA Approval for Gene Therapy ABEO Stock News
5/1/2025 - GuruFocus
Institutional investors control 44% of Abeona Therapeutics Inc. (NASDAQ:ABEO) and were rewarded last week after stock increased 22%
5/1/2025 - Simply Wall St
Abeona Therapeutics (ABEO, $6.56) RSI Indicator left the overbought zone on April 30, 2025
5/1/2025 - Tickeron - Technical Analysis
Abeona Therapeutics (ABEO, $6.56) price may drop as it broke higher Bollinger Band on Apr 30, 2025
5/1/2025 - Tickeron - Technical Analysis
FDA Approves First Cell-Based Gene Therapy For Rare Skin Disorder
5/1/2025 - Zero Hedge
Abeona Therapeutics (ABEO) Sees Price Target Boost Amid FDA Approval ABEO Stock News
4/30/2025 - GuruFocus
Abeona Therapeutics price target raised by $5 at H.C. Wainwright, here's why
4/30/2025 - The Fly
The volume for Abeona Therapeutics stock increased for two consecutive days, resulting in a record-breaking daily growth of 1,004% of the 65-Day Volume Moving Average
4/30/2025 - Tickeron - Stocks
Abeona Therapeutics Wins FDA Approval For First-of-Its-Kind Gene Therapy
4/29/2025 - Benzinga
Abeona Therapeutics (ABEO) Sees Price Target Boost Amid Zevaskyn Approval ABEO Stock News
4/29/2025 - GuruFocus
Abeona Therapeutics price target raised to $21 from $14 at Stifel
4/29/2025 - TipRanks Financial Blog
Abeona Therapeutics price target raised by $7 at Stifel, here's why
4/29/2025 - The Fly
Abeona Therapeutics' Gene Therapy Gets FDA Nod For Treating Rare Genetic Skin Disease
4/29/2025 - Stocktwits News Feed
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$62.21M
EBIT (TTM)
-$64.21M
Net Income (TTM)
-$63.73M
Balance Sheet
Total Assets (Q)
$108.93M
Total Debt (Q)
$23.05M
Total Liabilities (Q)
$64.90M
Book Value Per Share (Q)
$0.9647
Cash Flow
Cash from Operations (TTM)
-$56.02M
Cash from Investing (TTM)
-$39.24M
Cash from Financing (TTM)
$104.14M
Net Change in Cash (TTM)
$8.88M
Filings
Filing Date
Thursday, March 20, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Loading...
Beta
0.90
7-Day Total Return
-23.29%
30-Day Total Return
6.04%
60-Day Total Return
-11.13%
90-Day Total Return
-6.06%
Year to Date Total Return
-10.83%
1-Year Total Return
25.48%
2-Year Total Return
64.69%
3-Year Total Return
31.75%
5-Year Total Return
-93.49%
52-week Low
Apr 09, 2025 - $3.93
52-week High
Apr 30, 2025 - $7.32
Valuation
Market Cap
$255.77M - Micro Cap
Enterprise Value
$181.10M
Price/Sales (TTM)
--
Price/Book (Q)
5.46
Dividends and Shares
Shares Outstanding
48.68M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.abeonatherapeutics.com
Phone Number
646 813 4701
Address
6555 Carnegie Avenue
Cleveland, OH 44103
Country
United States
Year Founded
1974
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is pz-cel, an autologous... more
NASDAQ 05/09/2025 4:00PM Eastern Quotes delayed